Document Detail


Administered CpG oligodeoxynucleotide induces mRNA expression of CXC and CC chemokines at the intestinal mucosa and PBMCs in piglets.
MedLine Citation:
PMID:  20202485     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oligonucleotides containing CpG motifs (CpG ODN) are known to be potent stimulators of the innate immune system in vitro and in vivo. We therefore investigated if intranasal (IN)-mucosal or intramuscular (IM)-systemic administration of CpG ODN could enhance innate immunity in the intestinal mucosa and peripheral blood mononuclear cells (PBMCs) in piglets. Repeated IN or IM administration of CpG ODN significantly increased local/systemic mRNA expression of the CC chemokines macrophage inflammatory protein 1beta (MIP-1beta) and monocyte chemoattractant protein-1 (MCP-1) and CXC chemokine gamma interferon-inducible protein 10 (IP-10) and percentages of macrophages and cDCs in the intestine (jejunum, caecum and colon) and PBMCs by different kinetics. IN delivery of CpG ODN induced much stronger chemokine responses than IM delivery at intestinal mucosas, whereas IN delivery of CpG ODN induced some weaker chemokine responses than IM delivery in PBMCs. These findings suggest that IN administration of 100mug/kg-CpG ODN without antigen codelivery may represent a valuable strategy for induction of innate immunity against infection.
Authors:
Qing Cheng; Chenchao Xu; Linghua Zhang; Jiaoqing Li; Ting Cao; Meirong Zhang
Related Documents :
10769685 - Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor ...
14610275 - A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and ove...
15135735 - The potential of immunostimulatory cpg dna for inducing immunity against genital herpes...
19650625 - Modifications incorporated in cpg motifs of oligodeoxynucleotides lead to antagonist ac...
10395095 - Aminoguanidine induces constrictive vascular remodeling and inhibits smooth muscle cell...
18707455 - Immune defense and host life history.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-02
Journal Detail:
Title:  International immunopharmacology     Volume:  10     ISSN:  1878-1705     ISO Abbreviation:  Int. Immunopharmacol.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-13     Completed Date:  2010-09-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100965259     Medline TA:  Int Immunopharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  611-8     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier B.V. All rights reserved.
Affiliation:
College of Life Sciences, South China Agricultural University, Guangzhou 510642, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intranasal
Animals
Cell Count
Cell Movement / drug effects
Chemokine CCL2 / biosynthesis*,  genetics
Chemokine CCL4 / biosynthesis*,  genetics
CpG Islands / genetics
Dendritic Cells / pathology
Immunity, Innate
Injections, Intramuscular
Intestinal Mucosa / drug effects*,  immunology,  metabolism,  pathology
Leukocytes, Mononuclear / drug effects,  immunology,  metabolism,  pathology
Macrophages / pathology
Oligodeoxyribonucleotides / administration & dosage*,  genetics
Pyrimidinones / metabolism
RNA, Messenger / analysis*
Swine
Thiazoles / metabolism
Vaccination
Chemical
Reg. No./Substance:
0/Chemokine CCL2; 0/Chemokine CCL4; 0/Oligodeoxyribonucleotides; 0/Pyrimidinones; 0/RNA, Messenger; 0/Thiazoles; 89367-92-0/5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7H)-4,6-dione

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Crohn's Disease is a Risk Factor for Preterm Birth.
Next Document:  Modulation of transcription factor function by O-GlcNAc modification.